Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-dense modified TCF in advanced or metastatic gastric cancer
2007-004693-34Phase 2Completed
- Sponsor
- Gruppo Oncologico Italiano di Ricerca Clinica
- Start
- Feb 2008
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of docetaxel, cisplatin, levoleucovorin and fluorouracil in gastric cancer (GC), sponsored by Gruppo Oncologico Italiano di Ricerca Clinica. Primary endpoint: Overall response rate. Started Feb 2008; status: completed.
02
Drugs
docetaxelcisplatinlevoleucovorinfluorouracil
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on 2007-004693-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004693-34.